The present invention relates to novel dopamine D2 receptor ligands. The invention further relates to functionally-biased dopamine D2 receptor ligands and the use of these compounds for treating or preventing central nervous system and systemic disorders associated with dysregulation of dopaminergic activity. The present invention relates to novel compounds that modulate dopamine D2 receptors. In particular, compounds of the present invention show functional selectivity at the dopamine D2 rec...
Methods for the photocatalytic reduction of alkynes to alkenes with high conversion yields and selectivities using a heterogeneous system that incorporates a cobalt-porphyrin into a metal-organic framework (MOF) are provided. The cobalt-porphyrin-based MOFs carry out the photocatalytic reductions in the presence of a visible-light activated photosensitizer molecule and a sacrificial electron donor.
Disclosed herein are compositions and methods for the selective photocatalytic reduction of an alkyne compound to an alkene compound (e.g., acetylene to ethylene).
Disclosed herein are compositions and methods that can achieve photoreduction of CO2 to CO in pure water at pH 6-7 with excellent performance parameters. In embodiments, the compositions and methods use CuInS2 colloidal quantum dots (QDs) as photosensitizers, and a Co-porphyrin catalys